Robotic hair transplant
Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from DELHI AIIMS Hospital, Patna New City.
Robotic hair transplant
Dr.KåpîL ñd GulâtI..Best Comedy
12th year old girl Back & neck pain.
ASMR SCIATICA PAIN GONE
cervical spondylitits treatments
future robotics surgery
future healthcare techknology
future of healthcare video
12 year old girl emotional after treatment Treatment by chiropractic technique Delhi.
Full spine and tail bone adjustment in India
India's first coronavirus vaccine COVAXIN human trials are beginning today at the All India Institute of Medical Science (AIIMS), Delhi after its Ethics Committee gave its nod. COVAXIN is an indigenously developed COVID-19 vaccine candidate following which country's premier hospital is all set to begin the exercise by enrolling healthy volunteers from Monday.
AIIMS Delhi to start human trials of India's first coronavirus vaccine | All you need to know
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting phase I and II human trials of Covaxin.
In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.
Healthy volunteers having no comorbid conditions and without a history of COVID-19, aged more than 18 years and less than 55 years, would be eligible to participate in the randomised, double-blind, placebo-controlled clinical trial.
Few volunteers have already registered for the trial.
AIIMS will start the screening of the individuals and evaluate their health condition from Monday (today) onwards before vaccinating them.
COVID-19 vaccine candidate Covaxin, developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV), had recently got the nod for human clinical trials from the Drugs Controller General of India (DCGI).
Noting that this was the first indigenous vaccine being developed by India, ICMR Director General Dr Balram Bhargava in a letter to principal investigators of the 12 sites recently had asked them to fast-track the human clinical trial approvals stating it is one of the "top priority projects which is being monitored at the top-most level of the government".
The trials have so far started in AIIMS, Patna and some more sites.
How to participate in human trials of COVAXIN
Anybody willing to participate in the trial can send an email to [email protected] or an SMS to or call on 7428847499, he said. The institute may also put up these contact details on its website.
Since India is one of the largest vaccine producers in the world, it is the country's "moral responsibility" to fast-track vaccine development process to break the chain of coronavirus transmission, he had said.
DCGI approved two vaccines for Phase 1 and Phase 2 trials
The DCGI has permitted two vaccines -- one developed by the Bharat Biotech International Limited in collaboration with the ICMR and another one by Zydas Cadila Healthcare Ltd to go in for phase I and II human clinical trials.
Two vaccine candidates have undergone successful toxicity studies in rats, mice and rabbits and these data was submitted to DCGI following which both got clearance to start the early phase human trials early this month.
AIIMS collects 1,125 samples for human trials of India's first Covid-19 vaccine
Coronavirus Vaccine India: Clinical Trials Of Covaxin Will Start Today In AIIMS Delhi; Here Is How You Can Participate In The Human trails
Press Release: COMELEC to Resume Voter Registration on July 2
AIIMS 2016 MBBS Eligibility CriteriaFor Indian Nationals– In you’re an Indian Nationalyou have to be above the age of 17 years as on the31st of December of the year of admission. Thoseborn on or after 2nd January, 1996 are NOT eligible to apply for AIIMS.You must have cleared their 12th Grade, under the 10 + 2 Scheme or Senior qualifications School Certificate Examination or Intermediate Science (I. Sc.) or an equivalent examination of a reputedUniversity or Board of any Indian State with ENGLISH, PHYSICS, CHEMISTRY and BIOLOGY.You also must have scored minimum 60% aggregate marks for General and OBC; and 50% marks for SC or ST candidates in English, Physics, Chemistry and Biology.If have appeared or are appearing at the qualifying examination with English, Physics, Chemistry and Biology as their major subject and hoping to clear the examination with the required percentage of marks are also eligible toapply and appear in the Competitive Entrance Examination. Also, you will be accepted only if you give documentary proof or written evidenceof passing the qualifying examination with the required subjects and percentage of marks on or before the date mentioned.For Overseas Citizen of India (OCI)-If you are an OCI registered under Section 7A of CitizenshipAct 1955 then you are also eligible to give the test and all terms and conditions applicable forIndian Nationals will be applicable to you and you will need to give proof of the same.For Foreign Nationals– For AIIMS New Delhi, only Foreign candidates who are selected by the Indian Government need to have attained atleast aggregate 50% marks in all the subjects of ENGLISH, PHYSICS, CHEMISTRY and BIOLOGY in their Intermediate Science or an equivalent examination to be eligible for admission to the M. B. B. S. Course. Foreign candidates need not give the Competitive Entrance Examination
Patna New City
Be the first to know and let us send you an email when DELHI AIIMS Hospital posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to DELHI AIIMS Hospital: